FY2024 Earnings Forecast for Humana Issued By Zacks Research

Humana Inc. (NYSE:HUM) – Investment analysts at Zacks Research increased their FY2024 earnings per share estimates for Humana in a research report issued to clients and investors on Wednesday, November 13th. Zacks Research analyst D. Chatterjee now forecasts that the insurance provider will earn $16.04 per share for the year, up from their prior forecast of $16.01. The consensus estimate for Humana’s current full-year earnings is $15.83 per share. Zacks Research also issued estimates for Humana’s Q1 2025 earnings at $6.37 EPS and Q2 2025 earnings at $6.25 EPS.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%.

HUM has been the topic of several other reports. Stephens reiterated an “equal weight” rating and issued a $250.00 price target on shares of Humana in a report on Wednesday, October 9th. Royal Bank of Canada lowered their price target on Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Jefferies Financial Group downgraded Humana from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $519.00 to $253.00 in a report on Monday, October 7th. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and upped their target price for the stock from $247.00 to $308.00 in a report on Wednesday, November 6th. Finally, TD Cowen raised their price target on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $315.86.

Humana Trading Down 2.6 %

Shares of HUM opened at $275.67 on Friday. Humana has a twelve month low of $213.31 and a twelve month high of $527.18. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The company’s fifty day simple moving average is $283.00 and its 200-day simple moving average is $331.80. The company has a market cap of $33.19 billion, a P/E ratio of 24.47, a P/E/G ratio of 2.29 and a beta of 0.52.

Hedge Funds Weigh In On Humana

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Mendota Financial Group LLC increased its stake in shares of Humana by 9.2% during the second quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock worth $119,000 after purchasing an additional 27 shares in the last quarter. Capital Advisors Ltd. LLC increased its position in shares of Humana by 17.0% during the second quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock worth $80,000 after purchasing an additional 31 shares in the last quarter. CarsonAllaria Wealth Management Ltd. lifted its holdings in Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Moors & Cabot Inc. grew its holdings in shares of Humana by 2.5% during the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock worth $519,000 after buying an additional 40 shares in the last quarter. Finally, Harbour Investments Inc. raised its position in shares of Humana by 10.5% in the second quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock valued at $161,000 after buying an additional 41 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.28%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio is currently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.